{
    "title": "Individual feed for https://www.marketbeat.com/feed/",
    "link": "https://www.marketbeat.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-10-02T17:37:41.445055",
    "items": [
        {
            "title": "Nike’s Turnaround: If the Shoe Fits, Buy It!",
            "link": "https://www.marketbeat.com/originals/nikes-turnaround-if-the-shoe-fits-buy-it/",
            "description": "Nike is well-positioned to regain business momentum and create shareholder value. Analysts liked the Q1 report and signaled a rebound in stock prices.",
            "pubDate": "2025-10-02T17:16:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png"
        },
        {
            "title": "NVIDIA Breaks Out to New Highs: What Comes Next?",
            "link": "https://www.marketbeat.com/originals/nvidia-breaks-out-to-new-highs-what-comes-next/",
            "description": "NVIDIA's stock price breakout is bullish for its direction and the S&P 500. Analysts and technical targets align; a 20% upside lies ahead.",
            "pubDate": "2025-10-02T16:05:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        },
        {
            "title": "Microsoft Stock Hits Stride in 2025—How Much More Can It Run?",
            "link": "https://www.marketbeat.com/originals/microsoft-stock-hits-stride-in-2025how-much-more-can-it-run/",
            "description": "Microsoft stock is up 23% in 2025, but analysts see more upside ahead as AI and cloud growth fuel its consistent long-term performance",
            "pubDate": "2025-10-02T13:01:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "How Berkshire's OxyChem Buy Cements Its Long-Term Strength",
            "link": "https://www.marketbeat.com/originals/how-berkshires-oxychem-buy-cements-its-long-term-strength/",
            "description": "Berkshire Hathaway's multi-billion-dollar acquisition of OxyChem signals a strategic deployment of cash into a stable, long-term industrial earnings e...",
            "pubDate": "2025-10-02T12:37:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry",
            "link": "https://www.marketbeat.com/originals/oklo-insiders-sell-oh-no-this-is-why-investors-shouldnt-worry/",
            "description": "Oklo's insiders sold in Q2 and Q3, but this poses no threat to investors; institutions and analysts offset it, while short-sellers are a bigger risk.",
            "pubDate": "2025-10-02T12:28:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        }
    ]
}